The Psychedelic Wellness industry is Booming!

The World Health Organization says almost a billion people suffer from mental health problems. The Global Pandemic triggered significant emotional, physical, and economic problems around the world.

Psilocybin, the main ingredient in psychedelic mushrooms, could offer a new tool for mental health treatment. This company is an early mover in the psychedelic and functional mushroom space.

Still not sure? Read on.

Gloved hands examining mushrooms

This company intends to introduce new, safe, and affordable alternatives to current medicines. It operates in markets where psychedelics are legal (Oregon and Jamaica). It conducted the United States’ first-of-its-kind legal psychedelic-enhanced wellness retreat in Oregon in January 2021.

Pharmaceutical companies studied the use of psychedelics in psychiatry in the 1950s. According to JAMA Psychiatry, the U.S. National Institute of Health funded 130 studies exploring its utility.  It witnessed positive results in a range of disorders including anxiety, depression, and alcoholism. Political unrest disrupted its progress, forcing governments to ban the use of psychedelics in 1971.

This company established an online store that offers sixteen functional mushroom SKUs. The store soft-launched and is ready for rebranding. Part of the rebranding process was secured through an exclusive worldwide brand IP partnership with the estate of Bob Marley. The company developed the formulation of the first nasal spray in Jamaica and it is now patent pending.

Wondering how you can get exposure? This company began trading on the Canadian Securities Exchange in March.

Click here to find out more about this company operating in this nascent space.

Regards,
Dear Wallstreet

This is a PAID ADVERTISEMENT provided to customers of Schaeffer's Investment Research. Although we have sent you this email, Schaeffer's not specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above.

Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click here.

DISCLAIMER: In accordance with Section 17(b) of the Securities Act of 1933, you are hereby advised that Schaeffer's Investment Research, Inc. "Schaeffer's" is receiving a fee of over $1000.00 in cash, from an independent third party as compensation for the distribution of this advertisement. Schaeffer's has not determined if the statements and opinions of the advertiser are accurate, correct or truthful. The purpose of this advertisement, like any advertising, is to provide publicity for the advertising company, its products or services. You should not rely on the information presented; you should do independent research to form your own opinion and decision. Information contained in our disseminated emails does not constitute investment, legal or tax advice upon which you should rely. The purchase of high-risk securities may result in the loss of your entire investment.

Advertisements received by you are not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the States or other jurisdictions in which the security is eligible for sale. Advertisements distributed through disseminated emails are not disclosure documents. If you are considering purchasing any securities of an advertised company, you should call your State Securities Administrator to determine if the security may be sold in your State. Many companies have information filed with State securities regulators who may be able to supply you with additional information. You also should read and review, if and to the extent available, any information concerning an advertised company available at the websites of the U.S. Securities and Exchange Commission (the "SEC") and the Financial Industry Regulatory Authority (the "FINRA"). We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud on the SEC website, as well as related information published by the NASD on how to invest carefully. You are responsible for verifying all claims and conducting your own due diligence.

You agree and acknowledge that any hyperlinks to the website of (1) an advertised company, (2) the party issuing or preparing the information for the advertised company, or (3) other information contained in our disseminated emails is provided only for your reference and convenience. We are not responsible for the accuracy or reliability of these external sites, nor are we responsible for the content, advertising, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated email or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on us, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink. You also acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser. You acknowledge that you will consult with your own advisers regarding any decisions as to any advertised company.


Schaeffer's Investment Research
5151 Pfeiffer Road, Suite 250
Cincinnati, Ohio 45242

No comments:

Post a Comment